Poland· PL-100517688
Mastodynon
A other gynecologicals product containing agnus castus + caulophyllum thalictroides + cyclamen d4 + ignatia d6 + iris d2 + lilium tigrinum d3, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Agnus castus + caulophyllum thalictroides + cyclamen d4 + ignatia d6 + iris d2 + lilium tigrinum d3 is registered in 5 of 19 countries.
Countries holding a registration under ATC G02C (other gynecologicals), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Agnus castus + caulophyllum thalictroides + cyclamen d4 + ignatia d6 + iris d2 + lilium tigrinum d3 · ATC G02C
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Agnus castus + Caulophyllum thalictroides + Cyclamen D4 + Ignatia D6 + Iris D2 + Lilium tigrinum D3
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- G02C
- ATC class
- OTHER GYNECOLOGICALS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991573614
- gtin05909991573621
- gtin05909991573638
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G02C
Other gynecologicals, as other registers publish it.
- BelgiumDonnafyta MenoWill Pharma
- DenmarkFemilogesDr. Loges + Co. GmbH
- FinlandFemilogesDr. Loges + Co. GmbH
- DenmarkFemilogesDr. Loges + Co. GmbH
- BelgiumFemiloges 4 mgDr. Loges + Co.
- PolandFemimenoDr. Loges + Co. GmbH
- CzechiaFEMIPAUSEDr. Loges + Co. GmbH, Winsen (Luhe)
- CzechiaFEMIPAUSEDr. Loges + Co. GmbH, Winsen (Luhe)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2496af9a-935c-44a5-83e9-ce1fbf23723f GET /v1/drugs/2496af9a-935c-44a5-83e9-ce1fbf23723f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "162 mg + 81 mg + 81 mg + 81 mg + 162 mg + 81 mg",
"packaging": "05909991573614 ¦ OTC ¦ 161839\n60 tabl.\n05909991573621 ¦ OTC ¦ 161840\n120 tabl.\n05909991573638 ¦ OTC ¦ 161841\n240 tabl.",
"substance": "Agnus castus 162 mg + Caulophyllum thalictroides 81 mg + Cyclamen D4 81 mg + Ignatia D6 81 mg + Iris D2 162 mg + Lilium tigrinum D3 81 mg",
"common_name": "Agnus castus + Caulophyllum thalictroides + Cyclamen D4 + Ignatia D6 + Iris D2 + Lilium tigrinum D3",
"pl_product_id": "100517688",
"pozwolenie_nr": "161/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-04-30"
}See everything about agnus castus + caulophyllum thalictroides + cyclamen d4 + ignatia d6 + iris d2 + lilium tigrinum d3.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.